An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria

<p>Abstract</p> <p>Background</p> <p>Rapid diagnostic tests (RDTs) for malaria are increasingly being considered for routine use in Africa. However, many RDTs are available and selecting the ideal test for a particular setting is challenging. The appropriateness of RDT...

Full description

Bibliographic Details
Main Authors: Whitty Christopher JM, Hopkins Heidi, Lubell Yoel, Staedke Sarah G, Mills Anne
Format: Article
Language:English
Published: BMC 2008-01-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/7/1/21
_version_ 1818515285311750144
author Whitty Christopher JM
Hopkins Heidi
Lubell Yoel
Staedke Sarah G
Mills Anne
author_facet Whitty Christopher JM
Hopkins Heidi
Lubell Yoel
Staedke Sarah G
Mills Anne
author_sort Whitty Christopher JM
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Rapid diagnostic tests (RDTs) for malaria are increasingly being considered for routine use in Africa. However, many RDTs are available and selecting the ideal test for a particular setting is challenging. The appropriateness of RDT choice depends in part on patient population and epidemiological setting, and on decision makers' priorities. The model presented (available online) can be used by decision makers to evaluate alternative RDTs and assess the circumstances under which their use is justified on economic grounds.</p> <p>Methods</p> <p>An interactive model based on a decision-tree structure and a cost-benefit framework was designed to compare different diagnostic strategies. Variables included in the model can be modified by users, including RDT and treatment costs, test accuracies (sensitivity and specificity), probabilities for developing severe illness, case-fatality rates, and clinician response to negative test results. To illustrate how the model can be used, a comparison is made of presumptive treatment with two available RDTs, one detecting histidine-rich protein-2 (HRP2) and one detecting Plasmodium lactate dehydrogenase (pLDH). Data inputs were obtained from a study comparing the RDTs at seven sites in Uganda.</p> <p>Results</p> <p>Applying the model in the illustrative Ugandan context demonstrates that if only direct expenditures are considered, the pLDH test is the preferred option for adult patients except in high transmission settings, while young children are best treated presumptively in all settings. When health outcomes are considered, the HRP2 test gains an advantage in almost all settings and for all age groups. Introducing possible adverse consequences of using an antimalarial into the analysis, such as adverse drug reactions, or the development of resistance, considerably strengthens the case for using RDTs. When the model is adjusted to account for less than complete adherence to test results, the efficiency of using RDTs drops sharply.</p> <p>Conclusion</p> <p>Model output demonstrates that which test is preferable varies by location, depending on factors such as malaria transmission intensity and the costs and accuracies of the RDTs under consideration. Despite the uncertainties and complexities involved, adaptable models such as the one presented here can serve as a practical tool to assist policy makers in efficient deployment of new technologies.</p>
first_indexed 2024-12-11T00:27:00Z
format Article
id doaj.art-67a3399dd4ef49daac48de929eb1cd61
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-11T00:27:00Z
publishDate 2008-01-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-67a3399dd4ef49daac48de929eb1cd612022-12-22T01:27:30ZengBMCMalaria Journal1475-28752008-01-01712110.1186/1475-2875-7-21An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malariaWhitty Christopher JMHopkins HeidiLubell YoelStaedke Sarah GMills Anne<p>Abstract</p> <p>Background</p> <p>Rapid diagnostic tests (RDTs) for malaria are increasingly being considered for routine use in Africa. However, many RDTs are available and selecting the ideal test for a particular setting is challenging. The appropriateness of RDT choice depends in part on patient population and epidemiological setting, and on decision makers' priorities. The model presented (available online) can be used by decision makers to evaluate alternative RDTs and assess the circumstances under which their use is justified on economic grounds.</p> <p>Methods</p> <p>An interactive model based on a decision-tree structure and a cost-benefit framework was designed to compare different diagnostic strategies. Variables included in the model can be modified by users, including RDT and treatment costs, test accuracies (sensitivity and specificity), probabilities for developing severe illness, case-fatality rates, and clinician response to negative test results. To illustrate how the model can be used, a comparison is made of presumptive treatment with two available RDTs, one detecting histidine-rich protein-2 (HRP2) and one detecting Plasmodium lactate dehydrogenase (pLDH). Data inputs were obtained from a study comparing the RDTs at seven sites in Uganda.</p> <p>Results</p> <p>Applying the model in the illustrative Ugandan context demonstrates that if only direct expenditures are considered, the pLDH test is the preferred option for adult patients except in high transmission settings, while young children are best treated presumptively in all settings. When health outcomes are considered, the HRP2 test gains an advantage in almost all settings and for all age groups. Introducing possible adverse consequences of using an antimalarial into the analysis, such as adverse drug reactions, or the development of resistance, considerably strengthens the case for using RDTs. When the model is adjusted to account for less than complete adherence to test results, the efficiency of using RDTs drops sharply.</p> <p>Conclusion</p> <p>Model output demonstrates that which test is preferable varies by location, depending on factors such as malaria transmission intensity and the costs and accuracies of the RDTs under consideration. Despite the uncertainties and complexities involved, adaptable models such as the one presented here can serve as a practical tool to assist policy makers in efficient deployment of new technologies.</p>http://www.malariajournal.com/content/7/1/21
spellingShingle Whitty Christopher JM
Hopkins Heidi
Lubell Yoel
Staedke Sarah G
Mills Anne
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
Malaria Journal
title An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
title_full An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
title_fullStr An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
title_full_unstemmed An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
title_short An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
title_sort interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria
url http://www.malariajournal.com/content/7/1/21
work_keys_str_mv AT whittychristopherjm aninteractivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT hopkinsheidi aninteractivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT lubellyoel aninteractivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT staedkesarahg aninteractivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT millsanne aninteractivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT whittychristopherjm interactivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT hopkinsheidi interactivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT lubellyoel interactivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT staedkesarahg interactivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria
AT millsanne interactivemodelfortheassessmentoftheeconomiccostsandbenefitsofdifferentrapiddiagnostictestsformalaria